Joanna Wiensch
Stock Analyst at Citigroup
(2.53)
# 2,242
Out of 4,711 analysts
29
Total ratings
70%
Success rate
6.85%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Upgrades: Buy | $255 → $275 | $227.68 | +20.78% | 5 | Oct 1, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $114.23 | +11.18% | 8 | Aug 22, 2024 | |
| NVRO Nevro | Downgrades: Neutral | $40 | $3.79 | +955.41% | 1 | Jan 17, 2023 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $80.04 | +12.76% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $93.44 | -14.92% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $90.39 | +32.76% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $242.54 | -17.54% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $150.88 | -73.49% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $107.12 | +56.83% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $84.76 | -25.67% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $235 | $364.60 | -35.55% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $266.57 | -17.47% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $74.81 | +12.28% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $29.50 | +218.64% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $144.47 | +12.83% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $81.03 | +53.03% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Oct 1, 2024
Upgrades: Buy
Price Target: $255 → $275
Current: $227.68
Upside: +20.78%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $114.23
Upside: +11.18%
Nevro
Jan 17, 2023
Downgrades: Neutral
Price Target: $40
Current: $3.79
Upside: +955.41%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $80.04
Upside: +12.76%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $93.44
Upside: -14.92%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $90.39
Upside: +32.76%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $242.54
Upside: -17.54%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $150.88
Upside: -73.49%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $107.12
Upside: +56.83%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $84.76
Upside: -25.67%
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $364.60
Upside: -35.55%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $266.57
Upside: -17.47%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $74.81
Upside: +12.28%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $29.50
Upside: +218.64%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $144.47
Upside: +12.83%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $81.03
Upside: +53.03%